Results 191 to 200 of about 126,252 (290)

Barriers and Strategies for Inclusion of Value‐Based Healthcare in Contract Negotiations in the Netherlands: Study Among Hospital and Insurer Executives

open access: yesThe International Journal of Health Planning and Management, EarlyView.
ABSTRACT Background This paper analyses why, despite its recognized importance, value‐based healthcare (VBHC) has not gained more prominence in negotiations between health insurers and hospitals in the Netherlands. Methods Data collected by interviews used a standardized questionnaire with closed‐ and open‐ended questions. Respondents included hospital
Diogo L. L. Leao   +4 more
wiley   +1 more source

Extrachromosomal Circular DNA: Emerging Insights Into Cardiovascular Disease Mechanisms and Biomarker Potential

open access: yesiLABMED, EarlyView.
Extrachromosomal circular DNA (eccDNA) has quite recently turned out to be a cardinal component in cardiovascular diseases (CVD), governing the gene expression and mechanisms of disease causation. Studies indicated an upregulation of eccDNA in pulmonary arterial hypertension (PAH), which makes it strikingly potential as a sensitive and specific ...
Saim Mahmood Khan   +6 more
wiley   +1 more source

Metabolic and addiction indices in patients on opioid agonist medication-assisted treatment: A comparison of buprenorphine and methadone [PDF]

open access: yes, 2020
Albanese, Mark   +6 more
core   +1 more source

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

open access: yesiMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu   +8 more
wiley   +1 more source

Temporal response patterns of human gut microbiota to dietary fiber

open access: yesiMeta, EarlyView.
In this study, 19 overweight participants, with or without type 2 diabetes mellitus, underwent 14 days of normal‐diet observation followed by 14 days of dietary fiber intervention. Fecal samples and continuous glucose monitoring data were collected daily throughout the 28‐day period.
Xiaotong Lin   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy